CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a Phase III, 2-arm, randomized, open label, multicenter, global study assessing the efficacy and safety of puxitatug samrotecan compared to p...
Phase 3
White Plains, New York, United States and 153 other locations
letrozole in advanced stage, persistent or recurrent endometrioid endometrial cancer at 6 months. Treatment will continue until eit...
Phase 2
New Haven, Connecticut, United States and 28 other locations
The purpose of this study is to evaluate the activity and safety profile of mirvetuximab soravtansine (IMGN853) in patients with type II endometrial...
Phase 2
New Haven, Connecticut, United States
This study will test whether the combination of radiation and Dostarlimab is an effective treatment for women with MMR-D/MSI-H endometrial c...
Phase 2
Commack, New York, United States and 6 other locations
The researchers are doing this study to find out if ivonescimab is an effective treatment for people with endometrial cancer (EC) a...
Phase 2
Commack, New York, United States and 6 other locations
Researchers are looking for new ways to treat people with endometrial cancer (EC) who have previously received treatment with plati...
Phase 3
New Haven, Connecticut, United States and 243 other locations
This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who have ...
Phase 2, Phase 3
West Islip, New York, United States and 82 other locations
is an effective treatment for people with persistent or recurrent endometrial cancer or endometrial carcinosarcoma. The re...
Phase 2
Commack, New York, United States and 6 other locations
drug BMS-986205. Adding BMS-986208 to nivolumab could shrink the cancer or prevent it from returning, but it could also cause side effects....
Phase 2
Commack, New York, United States and 6 other locations
The goal of this clinical study is to find out how the study drug, sacituzumab govitecan (SG) works in participants with endometrial cancer...
Phase 3
New Haven, Connecticut, United States and 186 other locations
Clinical trials
Research sites
Resources
Legal